EUCTR2005-004155-35-BE进行中（未招募）不适用
A randomized, double blind, parallel group study to examine the effect of multiple doses of CJ-040,714 on distal esophageal acid exposure in patients with erosive gastro-esophageal reflux disease (gerd).
Pfizer Global Research & Development0 个研究点目标入组 24 人开始时间: 2006年7月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Male or female (non-child bearing potential) subject aged 18 to 70 years inclusive.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Subjects with a history of significant cardiovascular disease, e.g. ischemic heart disease, arrhythmias, QT prolongation, MI or stroke.
研究者
相似试验
进行中（未招募）
1 期
A randomized, double blind, parallel group study to examine the effect of multiple doses of CJ-040,714 on distal esophageal acid exposure an patients with erosive gastro-esophageal reflux disease (GERD). - N/AGastro-Esophageal Reflux Disease (GERD)MedDRA version: 8.0 Level: LLT Classification code 10017885EUCTR2005-004155-35-GBPfizer Limited24
已完成
不适用
To check the efficacy of cosmetic products in offering protection against skin stress inducers including pollutioCTRI/2021/02/031335ITC Limited ITC Life Sciences Technology Center98
招募中
2 期
GP-01 gel for the treatment of PsoriasisCTRI/2021/08/035763utrin GmbH
已完成
2 期
GA-01 gel for the treatment of Osteoarthritis with joint pain.CTRI/2021/03/031916utrin GmbH60
招募中
3 期
Probiotika off capsule for the treatment of Irritable Bowel SyndromeCTRI/2021/08/035848utrin GmbH